Based on these results, we suspected the patient had DM and measured autoantibodies specific to DM (Table 1), which yielded positive results for the antitranscriptional intermediary factor 1-γ (TIF1-γ) antibody, which is particularly positive in DM associated with malignancy. The gene discussed is TRIM33; the disease is diabetes mellitus.